Table 3 aORs from ordered logistic regression for participants eligible for ivermectin receiving a completed month of MDA
Variables associated with receiving ivermectin amongst the eligible population (by completed Nr of monthly MDAs) | ||||
|---|---|---|---|---|
aOR | 95% CI | p—value for specific variables | Likelihood Ratio—p—value | |
Household head receiving MDA | ||||
None | 1 | < 0.001 | ||
Complete | 1.71 | 1.35–2.14 | < 0.001 | |
Incomplete | 1.14 | 0.89–1.47 | 0.287 | |
Household size | ||||
< 6 | 1 | 0.0457 | ||
> 6–12 | 0.64 | 0.33–1.25 | 0.198 | |
> 12–25 | 0.75 | 0.39–1.42 | 0.379 | |
> 25–50 | 0.59 | 0.31–1.14 | 0.119 | |
> 50 | 0.53 | 0.26–1.05 | 0.069 | |
Ethnicity | ||||
Fula | 1 | < 0.001 | ||
Mandinka | 1.04 | 0.74–1.45 | 0.8 | |
Sarahule | 1.16 | 0.64–2.11 | 0.61 | |
Wollof | 1.14 | 0.11–11.5 | 0.911 | |
Not specified | 0.05 | 0.04–0.06 | < 0.001 | |
Age group | ||||
< 5 | 1.43 | 0.97–2.10 | 0.065 | < 0.001 |
> 5–15 | 4.3 | 3.51–5.28 | < 0.001 | |
> 15–25 | 0.92 | 0.73–1.14 | 0.45 | |
> 25–50 | 1 | |||
> 50 | 2.27 | 1.75–2.95 | < 0.001 | |
Sex | ||||
Female | 1 | < 0.001 | ||
Male | 1.54 | 1.31–1.81 | < 0.001 | |